Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system

European Journal of Pharmacology

Volumn 722, Issue 1, 2014, Pages 134-146

  Sharkey, Keith A ^a   Darmani, Nissar A ^b   Parker, Linda A ^c  

^a UNIVERSITY OF CALGARY   (Canada)

^b WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^c UNIVERSITY OF GUELPH   (Canada)

Author keywords

Brainstem; Cannabis; Cb1 receptor; Cb2 receptor; Emesis; Insular cortex; Serotonin

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ANANDAMIDE; BUSPIRONE; CANNABIDIOL; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABIS; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; DEXAMETHASONE; DEXANABINOL; DRONABINOL; ENDOCANNABINOID; FATTY ACID AMIDASE; JLZ 184; JZL 184; LITHIUM CHLORIDE; N (4 HYDROXY 2 METHYLPHENYL)ARACHIDONAMIDE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NABIXIMOLS; NEUROKININ 1 RECEPTOR ANTAGONIST; PROCHLORPERAZINE; RIMONABANT; SEROTONIN; SEROTONIN 3 ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANTICIPATORY NAUSEA AND VOMITING; ANTIEMETIC ACTIVITY; AVOIDANCE BEHAVIOR; BRAIN REGION; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CLINICAL TRIAL (TOPIC); CONDITIONED FLAVOR AVOIDANCE; CONDITIONED GAPING; CONDITIONING; DISEASE CONTROL; FLAVOR; GASTROINTESTINAL TRACT; HUMAN; LONG TERM EXPOSURE; LYING ON BELLY; NAUSEA; NAUSEA AND VOMITING; NONHUMAN; PICA; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; VOMITING;

BRAINSTEM; CANNABIS; CB(1) RECEPTOR; CB(2) RECEPTOR; EMESIS; INSULAR CORTEX; SEROTONIN;

ANIMALS; ANTIEMETICS; CANNABINOIDS; CONDITIONING (PSYCHOLOGY); ENDOCANNABINOIDS; HUMANS; NAUSEA; VOMITING;

EID: 84892899650     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.09.068     Document Type: Review

References (199)

1. A. Abrahamov, A. Abrahamov, and R. Mechoulam An efficient new cannabinoid antiemetic in pediatric oncology Life Sci. 56 1995 2097 2102
2. S. Ahmedzai, D.L. Carlyle, I.T. Calder, and F. Moran Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy Br. J. Can 48 1983 657 663
3. B.E. Alger, and J. Kim Supply and demand for endocannabinoids Trends Neurosci. 34 2011 304 315
4. J.H. Allen, G.M. de Moore, R. Heddle, and J.C. Twartz Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse Gut 53 2004 1566 1570
5. P.L. Andrews, and P. Bhandari The 5-hydroxytryptamine receptor antagonists as antiemetics: preclinical evaluation and mechanism of action Eur. J. Cancer 29A Suppl. 1 1993 S11 S16
6. P.L. Andrews, and C.C. Horn Signals for nausea and emesis: implications for models of upper gastrointestinal diseases Auton. Neurosci 125 2006 100 115
7. J.H. Baek, Y. Zheng, C.L. Darlington, and P.F. Smith Cannabinoid CB2 receptor expression in the rat brainstem cochlear and vestibular nuclei Acta Otolaryngol. 128 2008 961 967
8. J. Bergman, M.S. Delatte, C.A. Paronis, K. Vemuri, G.A. Thakur, and A. Makriyannis Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties Physiol. Behav. 93 2008 666 670
9. I.L. Bernstein, M. Chavez, D. Allen, and E.M. Taylor Area postrema mediation of physiological and behavioral effects of lithium chloride in the rat Brain Res. 575 1992 132 137
10. I. Billig, B.J. Yates, and L. Rinaman Plasma hormone levels and central c-Fos expression in ferrets after systemic administration of cholecystokinin Am. J. Physiol. Regul. Integr. Comp. Physiol 281 2001 R1243 R1255
11. J.L. Blankman, and B.F. Cravatt Chemical probes of endocannabinoid metabolism Pharmacol. Rev. 65 2013 849 871
12. J.L. Blankman, G.M. Simon, and B.F. Cravatt A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol Chem. Biol. 14 2007 1347 1356
13. F.M. Boissonade, K.A. Sharkey, and J.S. Davison Fos expression in ferret dorsal vagal complex after peripheral emetic stimuli Am. J. Physiol. 266 1994 R1118 R1126
14. D. Bolognini, E.M. Rock, N.L. Cluny, M.G. Cascio, C.L. Limebeer, M. Duncan, C.G. Stott, F.A. Javid, L.A. Parker, and R.G. Pertwee Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation Br. J. Pharmacol. 168 2013 1456 1470
15. H.L. Borison, R. Borison, and L.E. McCarthy Phylogenic and neurologic aspects of the vomiting process J. Clin. Pharmacol. 21 1981 23S 29S
16. H.L. Borison, and S.C. Wang Physiology and pharmacology of vomiting Pharmacol. Rev. 5 1953 193 230
17. A. Brusco, P.A. Tagliaferro, T. Saez, and E.S. Onaivi Ultrastructural localization of neuronal brain CB2 cannabinoid receptors Ann. N.Y. Acad. Sci 1139 2008 450 457
18. S.R. Burchfield, M.S. Elich, and S.C. Woods Geophagia in response to stress and arthritis Physiol. Behav. 19 1977 265 267
19. G. Burdyga, S. Lal, A. Varro, R. Dimaline, D.G. Thompson, and G.J. Dockray Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin J. Neurosci. 24 2004 2708 2715
20. G. Burdyga, A. Varro, R. Dimaline, D.G. Thompson, and G.J. Dockray Expression of cannabinoid CB1 receptors by vagal afferent neurons: kinetics and role in influencing neurochemical phenotype Am. J. Physiol. Gastrointest. Liver Physiol. 299 2010 G63 G69
21. L. Callen, E. Moreno, P. Barroso-Chinea, D. Moreno-Delgado, A. Cortes, J. Mallol, V. Casado, J.L. Lanciego, R. Franco, C. Lluis, E.I. Canela, and P.J. McCormick Cannabinoid receptors CB1 and CB2 form functional heteromers in brain J. Biol. Chem. 287 2012 20851 20865
22. M.P. Carey, T.G Burish, and D.E. Brenner Delta-9-tetrahydrocannabinol in cancer chemotherapy: research problems and issues Ann. Intern. Med. 99 1983 106 114
23. D.O. Carpenter Neural mechanisms of emesis Can. J. Physiol. Pharmacol. 68 1990 230 236
24. P.E. Castillo, T.J. Younts, A.E. Chavez, and Y. Hashimotodani Endocannabinoid signaling and synaptic function Neuron 76 2012 70 81
25. H. Catenoix, J. Isnard, M. Guénot, J. Petit, C. Remy, and F. Mauguiére The role of the anterior insular cortex in ictal vomiting: a stereotactic electroencephalography study Epilepsy Behav. 13 2008 560 563
26. D.F. Cechetto, and C.B. Saper Evidence for a viscerotopic sensory representation in the cortex and thalamus in the rat J. Comp. Neurol. 262 1987 27 45
27. A.P. Chambers, H.S. Koopmans, Q.J. Pittman, and K.A. Sharkey AM 251 produces sustained reductions in food intake and body weight that are resistant to tolerance and conditioned taste aversion Br. J. Pharmacol. 147 2006 109 116
28. A.P. Chambers, V.K. Vemuri, Y. Peng, J.T. Wood, T. Olszewska, Q.J. Pittman, A. Makriyannis, and K.A. Sharkey A neutral CB1 receptor antagonist reduces weight gain in rat Am. J. Physiol. Regul. Integr. Comp. Physiol 293 2007 R2185 R2193
29. M.Y. Chan, S.K. Cross-Mellor, M. Kavaliers, and K.-P. Ossenkopp Lipopolysaccharide (LPS) blocks the acquisition of LiCl-induced gaping in a rodent model of anticipatory nausea Neurosci. Lett. 450 2009 301 305
30. A.E. Chang, D.J. Shiling, R.C. Stillman, N.H. Goldberg, C.A. Seipp, I. Barofsky, R.M. Simon, and S.A. Rosenberg Delata-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation Ann. Intern. Med. 91 1979 819 824
31. H.J. Chial, M. Camilleri, D. Burton, G. Thomforde, K.W. Olden, and D. Stephens Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health Am. J. Physiol. Gastrointest. Liver Physiol. 28 2003 G130 G137
32. A. Choukèr, I. Kaufmann, S. Kreth, D. Hauer, M. Feuerecker, D. Thieme, M. Vogeser, M. Thiel, and G. Schelling Motion sickness, stress and the endocannabinoid system PLoS One 5 2010 e10752
33. K.M. Chu, M.P. Ngan, M.K. Wai, C.K. Yeung, P.L. Andrews, S.N. Percie du, and J.A. Rudd Olvanil: a non-pungent TRPV1 activator has anti-emetic properties in the ferret Neuropharmacology 58 2010 383 391
34. N.L. Cluny, K. Vemuri, A. Chambers, C.L. Limebeer, H. Bedard, J. Wood, B. Lutz, A. Zimmer, L.A. Parker, A. Makriyannis, and K.A. Sharkey A novel, peripherally restricted, cannabinoid 1 (CB1) receptor antagonist AM6545 reduces food intake and body weight, but does not cause malaise, in rodents Br. J. Pharmacol. 161 2010 629 642
35. M. Contreras, F. Ceric, and F. Torrealba Inactivation of the interoceptive insula disrupts drug craving and malaise induced by lithium Science 318 2007 655 658
36. J. Cotter Efficacy of crude marijuana and synthetic delta-9- Tetrahydrocannabinol as treatment for chemotherapy-induced nausea and vomiting: a systematic literature review Oncol. Nurs. Forum 36 2009 345 352
37. A.D. Craig How do you feel? Interoception: the sense of the physiological condition of the body Nat. Rev. Neurosci. 3 2002 655 666
38. S.M. Crawford, and R. Buckman Nabilone and metoclopramide in the treatment of nausea and vomiting due to cisplatinum: a double blind study Med. Oncol. Tumor Pharmacother 3 1986 39 42
39. S.K. Cross-Mellor, K.P. Ossenkopp, D. Piomelli, and L.A. Parker Effects of the FAAH inhibitor, URB597, and anandamice on lithium-induced taste reactivity responses: a measure of nausea in rats Psychopharmacology 190 2007 135 143
40. D. Cunningham, C.J. Bradley, G.J. Forrest, A.W. Hutcheon, L. Adams, M. Sneddon, M. Harding, D.J. Kerr, M. Soukop, and S.B. Kaye A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues Eur. J. Cancer Clin. Oncol. 24 1988 685 689
41. A.M. Dalzell, H. Bartlett, and J.S. Lilleyman Nabilone: an alternative antiemetic for cancer chemotherapy Arch. Dis. Childhood 61 1986 502 505
42. N.A. Darmani Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB(1) receptor antagonist/inverse agonist SR 141716A Neuropsychopharmacology 24 2001 198 203
43. N.A. Darmani Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB(1) receptors in the least shrew Pharmacol. Biochem. Behav 69 2001 239 249
44. N.A. Darmani The cannabinoid CB1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2 Eur. J. Pharmacol 430 2001 49 58
45. N.A. Darmani, and S. Chebolu The role of endocannabinoids and arachidonic acid metabolites in emesis E. Murillo-Rodriguez, Endocannabinoids: Molecular, Pharmacological, Behavioral and Clinical Features 2013 Bentham Science Publishers Sharjah, UAE 25 59
46. 3 receptor agonists in the least shrew (Cryptotis parva) Pharmacol. Biochem. Behav 80 2005 35 44
47. N.A. Darmani, J.J. Janoyan, N. Kumar, and J.L. Crim Behaviorally active doses of the CB1 receptor antagonist SR 141716A increase brain serotonin and dopamine levels and turnover Pharmacol. Biochem. Behav. 75 2003 777 787
48. N.A. Darmani, B.A. McClanahan, C. Trinh, S. Petrosino, M. Valenti, and V. Di Marzo Cisplatin increases brain 2-arachidonoylglycerol (2-AG) and concomitantly reduces intestinal 2-AG and anandamide levels in the least shrew Neuropharmacology 49 2005 502 513
49. N.A. Darmani, L.J. Sim-Selley, B.R. Martin, J.J. Janoyan, J.L. Crim, B. Parekh, and C.S. Breivogel Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation Eur. J. Pharmacol. 459 2003 83 95
50. J. De Vry, R. Schreiber, G. Eckel, and K.R. Jentzsch Behavioral mechanisms underlying inhibition of food-maintained responding by the cannabinoid receptor antagonist/inverse agonist SR141716A Eur. J. Pharmacol. 483 2004 55 63
51. F.S. den Boon, P. Chameau, Q. Schaafsma-Zhao, W. van Aken, M. Bari, S. Oddi, C.G. Kruse, M. Maccarrone, W.J. Wadman, and T.R. Werkman Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors Proc. Nat. Acad. Sci. U.S.A 109 2012 3534 3539
52. A.V. Derbenev, T.C. Stuart, and B.N. Smith Cannabinoids suppress synaptic input to neurones of the rat dorsal motor nucleus of the vagus nerve J. Physiol. 559 2004 923 938
53. J.P. Despres, R. Ross, G. Boka, N. Almeras, and I. Lemieux Effect of rimonabant on the high-triglyceride/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial Arterioscler. Thromb. Vasc. Biol. 29 2009 416 423
54. V. Di Marzo, and L. De Petrocellis Why do cannabinoid receptors have more than one endogenous ligand? Philos. Trans. R. Soc. London B Biol. Sci 367 2012 3216 3228
55. T.P. Dinh, D. Carpenter, F.M. Leslie, T.F. Freund, I. Katona, S.L. Sensi, S. Kathuria, and D. Piomelli Brain monoglyceride lipase participating in endocannabinoid inactivation Proc. Nat. Acad. Sci. U.S.A 99 2002 10819 10824
56. M. Duran, E. Pérez, S. Abanades, X. Vidal, C. Saura, M. Majem, E. Arriola, M. Rabanal, A. Pastor, M. Farré, N. Rams, J.R. Laporte, and D. Capellà Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting Br. J. Clin. Pharmacol. 70 2010 656 663
57. L. Edvinsson, C.M. Villalon, and A. MaassenVanDenBrink Basic mechanisms of migraine and its acute treatment Pharmacol. Ther. 136 2012 319 333
58. M. Egertova, G.M. Simon, B.F. Cravatt, and M.R. Elphick Localization of N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) expression in mouse brain: a new perspective on N-acylethanolamines as neural signaling molecules J. Comp. Neurol 506 2008 604 615
59. H. Ekert, K.D. Waters, I.H. Jurk, J. Mobilia, and P. Loughnan Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol Med. J. Aust 2 1979 657 659
60. D. Fegley, S. Gaetani, A. Duranti, A. Tontini, M. Mor, and G. Tarzia et al. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB-597): effects on anandamide and oleoylethanolamide deactivation J. Pharmacol. Exp. Ther. 313 2005 352 358
61. M. Fiol, I.E. Leppik, R. Mireless, and R. Maxwell Ictus emeticus and the insular cortex Epilepsy Res. 2 1988 127 131
62. B. Forget, A. Pushparaj, and F.B. Le Granular insular cortex inactivation as a novel therapeutic strategy for nicotine addiction Biol. Psychiatry 68 2010 265 271
63. T.F. Freund, I. Katona, and D. Piomelli Role of endogenous cannabinoids in synaptic signaling Physiol. Rev. 83 2003 1017 1066
64. S. Frytak, C.G. Moertel, J.R. O'Fallon, J. Rubin, E.T. Creagan, M.J. O'Connell, A.J. Schutt, and N.W. Schwartau Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo Ann. Intern. Med. 91 1979 825 830
65. J.A. Galli, R.A. Sawaya, and F.K. Friedenberg Cannabinoid hyperemesis syndrome Curr. Drug Abuse Rev 4 2011 241 249
66. Y. Gao, D.V. Vasilyev, M.B. Goncalves, F.V. Howell, C. Hobbs, M. Reisenberg, R. Shen, M.Y. Zhang, B.W. Strassle, P. Lu, L. Mark, M.J. Piesla, K. Deng, E.V. Kouranova, R.H. Ring, G.T. Whiteside, B. Bates, F.S. Walsh, G. Williams, M.N. Pangalos, T.A. Samad, and P. Doherty Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice J. Neurosci. 30 2010 2017 2024
67. Y. Gaoni, and R. Mechoulam Isolation, structure, and partial synthesis of an active constituent of hashish J. Am. Chem. Soc. 86 1964 1646 1647
68. J. Garcia, W.G. Hankins, and K.W. Rusiniak Behavioral regulation of the milieu interne in man and rat Science 185 1974 824 831
69. G. Gobbi, F.R. Vambico, R. Manqieri, M. Bortalato, P. Campolongo, and M. Sollinas et al. Antidepressant like activity and modulation of brain monominergic transmission by blockade of anandamide hydrolysis Proc. Nat. Acad. Sci. U.S.A. 102 2005 18620 18625
70. J.P. Gong, E.S. Onaivi, H. Ishiguro, Q.R. Liu, P.A. Tagliaferro, A. Brusco, and G.R. Uhl Cannabinoid CB2 receptors: immunohistochemical localization in rat brain Brain Res. 1071 2006 10 23
71. H.C. Grill, and R. Norgren The taste reactivity test. I: Mimetic responses to gustatory stimuli in neurologically normal rats Brain Res. 14 1978 263 279
72. Y. Grunfeld, and H. Edery Psychopharmacological activity of the active constituents of hashish and some related cannabinoids Psychopharmacology 14 1969 200 210
73. A.I. Gulyas, B.F. Cravatt, M.H. Bracey, T.P. Dinh, D. Piomelli, F. Boscia, and T.F. Freund Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala Eur. J. Neurosci. 20 2004 441 458
74. P. Gyombolai, D. Pap, G. Turu, K.J. Catt, G. Bagdy, and L. Hunyady Regulation of endocannabinoid release by G proteins: a paracrine mechanism of G protein-coupled receptor action Mol. Cell Endocrinol. 353 2012 29 36
75. T.S. Herman, L.H. Einhorn, S.E. Jones, C. Nagy, A.B. Chester, J.C. Dean, B. Furnas, S.D. Williams, S.A. Leigh, R.T. Dorr, and T.E. Moon Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy New Engl. J. Med 300 1979 1295 1297
76. P.J. Hesketh Management of Nausea and Vomiting in Cancer and Cancer Treatment 2005 Jones and Bartlett Learning Boston
77. J.T. Hickok, J.A. Roscoe, G.R. Morrow, D.K. King, J.N. Atkins, and T.R. Fitch Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: a university of Rochester James P. Wilmot cancer center community clinical oncology program study of 360 cancer patients treated in the community Cancer 97 2003 2880 2886
78. K. Hillsley, and D. Grundy Serotonin and cholecystokinin activate different populations of rat mesenteric vagal afferents Neurosci. Lett. 255 1998 63 66
79. C.C. Horn Why is the neurobiology of nausea and vomiting so important? Appetite 50 2008 430 434
80. C.C. Horn, E.J. Richardson, P.L. Andrews, and M.L. Friedman Differential effects on gastrointestinal and hepatic vagal afferent fibers in the rat by the anti-cancer agent cisplatin Auton. Neurosci 115 2004 74 81
81. Horn, C.C., Kimball, B.A., Wang, H., Kaus, J., Dienel, S., Nagy, A., Gathright, G.R., Yates, B.J., Andrews, P.L.R., 2013, Why can't rodents vomit? A comparative behavioral, anatomical, and physiological study. PLoS One 8, e60537.
82. P.J. Hornby Central neurocircuitry associated with emesis Am. J. Med 111 Suppl. 8A 2001 106S 112S
83. A.C. Howlett, F. Barth, T.I. Bonner, G. Cabral, P. Casellas, W.A. Devane, C.C. Felder, M. Herkenham, K. Mackie, B.R. Martin, R. Mechoulam, and R.G. Pertwee International Union of Pharmacology. XXVII. Classification of cannabinoid receptors Pharmacol. Rev. 54 2002 161 202
84. D.L. Hu, G. Zhu, F. Mori, K. Omoe, M. Okada, K. Wakabayashi, S. Kaneko, K. Shinagawa, and A. Nakane Staphylococcal enterotoxin induces emesis through increasing serotonin release in intestine and it is downregulated by cannabinoid receptor 1 Cell Microbiol. 9 2007 2267 2277
85. L.L. Iversen The Science of Marijuana second ed. 2008 Oxford University Press New York
86. A.A. Izzo, and K.A. Sharkey Cannabinoids and the gut: new developments and emerging concepts Pharmacol. Ther. 126 2010 21 38
87. J. Jelsing, P.J. Larsen, and N. Vrang The effect of leptin receptor deficiency and fasting on cannabinoid receptor 1 mRNA expression in the rat hypothalamus, brainstem and nodose ganglion Neurosci. Lett 463 2009 125 129
88. B.R. Kaada Somato-motor, autonomic and electrocorticographic responses to electrical stimulation of rhinencephalic and other structures in primates, cat, and dog; a study of responses from the limbic, subcallosal, orbito-insular, piriform and temporal cortex, hippocampus-fornix and amygdala Acta Physiol. Scand Suppl. 24 1951 1 262
89. M. Kaczocha, S. Vivieca, J. Sun, S.T. Glaser, and D.G. Deutsch Fatty acid-binding proteins transport N-acylethanolamines to nuclear receptors and are targets of endocannabinoid transport inhibitors J. Biol. Chem. 287 2012 3415 3424
90. H. Kalant Medicinal use of cannabis: history and current status Pain Res. Manag 6 2001 80 91
91. M. Kano, T. Ohno-Shosaku, Y. Hashimotodani, M. Uchigashima, and M. Watanabe Endocannabinoid-mediated control of synaptic transmission Physiol. Rev. 89 2009 309 380
92. I. Katona, and T.F. Freund Multiple functions of endocannabinoid signaling in the brain Annu. Rev. Neurosci. 35 2012 529 558
93. S.W. Kiefer, and M.R. Orr Taste avoidance, but not aversion, learning in rats lacking gustatory cortex Behav. Neurosci. 106 1992 140 146
94. J. Kim, and B.E. Alger Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses Nat. Neurosci. 13 2010 592 600
95. M.S. Kipnes, P. Hollander, K. Fujioka, I. Gantz, T. Seck, N. Erondu, Y. Shentu, K. Lu, S. Suryawanshi, M. Chou, A.O. Johnson-Levonas, S.B. Heymsfield, D. Shapiro, K.D. Kaufman, and J.M. Amatruda A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes Diabetes Obes. Metab. 12 2010 517 531
96. ® has beneficial pharmacokinetics and promising pharmacodynamic effects Br. J. Clin. Pharmacol. 74 2012 42 53
97. K.L. Koch Diabetic gastropathy: gastric neuromuscular dysfunction in diabetes mellitus: a review of symptoms, pathophysiology, and treatment Dig. Dis. Sci. 44 1999 1061 1075
98. P. Kranke, K.D. Röhm, P. Diemunsch, T.J. Gan, C.C. Apfel, L. Eberhart, H.S. Minkowitz, J. Wallenborn, D. Chassard, G. Lebuffe, G.M. Fox, and M.R. Tramér Intravenous buspirone for the prevention of postoperative nausea and vomiting Eur. J. Clin. Pharmacol. 68 2012 1465 1472
99. M. Kwiatkowska, L.A. Parker, P. Burton, and R. Mechoulam A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew) Psychopharmacology (Berl) 174 2004 254 259
100. M.R. Landauer, R.L. Balster, and L.S. Harris Attenuation of cyclophosphamide-induced taste aversions in mice by prochlorperazeine, delta 9-tetraydrocannabinol, nbilone and levonantradol, Pharmacol. Biochem. Behav. 23 1985 259 266
101. M. Lane, C.L. Vogel, J. Ferguson, S. Krasnow, J.L. Saiers, J. Hamm, K. Salva, P.H. Wiernik, C.P. Holroyde, and S. Hammill et al. Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting J. Pain Symptom. Manage 6 1991 352 359
102. D. Leung, A. Saghatelian, G.M. Simon, and B.F. Cravatt Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids Biochemistry 45 2006 4720 4726
103. Limebeer, C.L., Abdullah, R.A., Rock E.M., Imhof, E., Wang, K., Lichtman, A.H., Parker, L.A., 2013. Effect of manipulation of the endocannabinoid system on contextually-elicited conditioned gaping reactions in rats: A model of anticipatory nausea. Psychopharmacology. In press.
104. C.L. Limebeer, G. Hall, and L.A. Parker Exposure to a lithium-paired context elicits gaping in rats: a model of anticipatory nausea Physiol. Behav. 88 2006 398 403
105. C.L. Limebeer, J.P. Krohn, S. Cross-Mellor, K.-P. Ossenkopp, and L.A. Parker Exposure to a context previously associated with toxin (LiCl)- or motion-induced sickness elicits conditioned gaping in rats: evidence in support of a model of anticipatory nausea Behav. Brain Res 187 2008 33 40
106. C.L. Limebeer, and L.A. Parker Delta-9-tetrahydrocannabinol interferes with the establishment and the expression of conditioned rejection reactions produced by cyclophosphamide: a rat model of nausea Neuroreport 10 1999 3769 3772
107. C.L. Limebeer, E.M. Rock, R. Mechoulam, and L.A. Parker The anti-nausea effects of CB1 agonists are mediated by an action at the visceral insular cortex Br. J. Pharmacol. 167 2012 126 136
108. C.L. Limebeer, V.K. Vemuri, H. Bedard, S.T. Lang, K.P. Ossenkopp, A. Makriyannis, and L.A. Parker Inverse agonism of cannabinoid CB1 receptors potentiates LiCl-induced nausea in the conditioned gaping model in rats Br. J. Pharmacol. 161 2010 336 349
109. J. Liu, L. Wang, J. Harvey-White, B.X. Huang, H.Y. Kim, S. Luquet, R.D. Palmiter, G. Krystal, R. Rai, A. Mahadevan, R.K. Razdan, and G. Kunos Multiple pathways involved in the biosynthesis of anandamide Neuropharmacology 54 2008 1 7
110. J. Liu, L. Wang, J. Harvey-White, D. Osei-Hyiaman, R. Razdan, Q. Gong, A.C. Chan, Z. Zhou, B.X. Huang, H.Y. Kim, and G. Kunos A biosynthetic pathway for anandamide Proc. Nat. Acad. Sci. U.S.A 103 2006 13345 13350
111. Y.L. Liu, N. Malik, G.J. Sanger, M.I. Friedan, and P.L. Andrews Pica - a model of nausea? Species differences in response to cisplatin Physiol. Behav. 85 2005 271 277
112. J.Z. Long, and B.F. Cravatt The metabolic serine hydrolases and their functions in mammalian physiology and disease Chem. Rev. 111 2011 6022 6063
113. J.Z. Long, D.K. Nomura, R.E. Vann, D.M. Walentiny, L. Booker, X. Jin, J.J. Burston, L.J. Sim-Selley, A.H. Lichtman, J.L. Wiley, and B.F. Cravatt Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo Proc. Nat. Acad. Sci. U.S.A 106 2009 20270 20275
114. K. Mackie Distribution of cannabinoid receptors in the central and peripheral nervous system Handb. Exp. Pharmacol 2005 299 325
115. W.R. Marrs, J.L. Blankman, E.A. Horne, A. Thomazeau, Y.H. Lin, J. Coy, A.L. Bodor, G.G. Muccioli, S.S. Hu, G. Woodruff, S. Fung, M. Lafourcade, J.P. Alexander, J.Z. Long, W. Li, C. Xu, T. Moller, K. Mackie, O.J. Manzoni, B.F. Cravatt, and N. Stella The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors Nat. Neurosci. 13 2010 951 957
116. I.S. McGregor, C.N. Issakidis, and G. Prior Aversive effects of the synthetic cannabinoid CP 55,940 in rats Pharmacol. Biochem. Behav. 53 1996 657 664
117. P.J. McLaughlin, K.M. Winston, C.L. Limebeer, L.A. Parker, A. Makriyannis, and J.D. Salamone The cannabinoid CB1 antagonist AM 251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats Psychopharmacology 180 2005 286 293
118. R. Mechoulam, L.A. Parker, and R. Gallily Cannabidiol: An overview of some chemical and pharmacological aspects. Part II: Pharmacological aspects J. Clin. Pharmacol. 12 2002 5 20
119. R. Mechoulam, and L.A. Parker The endocannabinoid system and the brain Ann. Rev. Psychol 64 2013 21 47
120. E. Meiri, H. Jhangiani, J.J. Vredenburgh, L.M. Barbato, F.J. Carter, H.M. Yang, and V. Baranowski Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting Cur. Med. Res. Opin 23 2007 533 543
121. A.D. Miller Central mechanisms of vomiting Dig. Dis. Sci. 44 1999 39S 43S
122. A.D. Miller, and R.A. Leslie The area postrema and vomiting Front. Neuroendocrinol. 15 1994 301 320
123. A.D. Miller, and D.A. Ruggiero Emetic reflex arc revealed by expression of the immediate-early gene c-fos in the cat J. Neurosci 14 1994 871 888
124. R. Min, V. Di Marzo, and H.D. Mansvelder DAG lipase involvement in depolarization-induced suppression of inhibition: does endocannabinoid biosynthesis always meet the demand? Neuroscientist 16 2010 608 613
125. D. Mitchell, C. Wells, N. Hoch, K. Lind, S.C. Woods, and L.K. Mitchell Poison induced pica in rats Physiol. Behav. 17 1976 691 697
126. G. Moldrich, and T. Wenger Localization of the CB1 cannabinoid receptor in the rat brain. An immunohistochemical study Peptides 21 2000 1735 1742
127. T.F. Mott, M.L. McConnon, and B.P. Rieger Subacute to chronic mild traumatic brain injury Am. Fam. Physician 86 2012 1045 1051
128. V. Napadow, J.D. Sheehan, J. Kim, L.T. Lacount, K. Park, T.J. Kaptchuk, B.R. Rosen, and B. Kuo The brain circuitry underlying the temporal evolution of nausea in humans Cereb. Cortex 23 2013 806 813
129. N.H. Naqvi, and A. Bechara The hidden island of addiction: the insula Trends Neurosci. 32 2009 56 67
130. R.J. Naylor, and J.A. Rudd Mechanisms of chemotherapy/radiotherapy- induced emesis in animal models Oncology 53 Suppl. 1 1996 8 17
131. S.E. Nicolson, L. Denysenko, J.L. Mulcare, J.P. Vito, and B. Chabon Cannabinoid hyperemesis syndrome: a case series and review of previous reports Psychosomatics 53 2012 212 219
132. O'Brien, L.D., Limebeer, C.L., Rock, E.M., Bottegoni G., Piomelli, D., Parker, L.A., 2013. Anandamide transport inhibition by ARN272 attenuates nausea-induced behaviour in rats, and vomiting in shrews (Suncus murinus), Br. J. Pharmacol. 170, 1130-1136.
133. E.S. Onaivi, H. Ishiguro, S. Gu, and Q.R. Liu CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity J. Psychopharmacol. 26 2012 92 103
134. L.E. Orr, and J.F. McKernan Antiemetic effect of delta 9-tetrahydrocannabinol in chemotherapy-associated nausea and emesis as compared to placebo and compazine J. Clin. Pharmacol 21 1981 76S 80S
135. L.E. Orr, J.F. McKernan, and B. Bloome Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis Arch. Intern. Med. 140 1980 1431 1433
136. P. Pacher, and R. Mechoulam Is lipid signaling through cannabinoid 2 receptors part of a protective system? Prog. Lipid Res 50 2011 193 211
137. L.A. Parker, and T. Gillies THC-induced place and taste aversions in Lewis and Sprague-Dawley rats Behav. Neurosci. 109 1995 71 78
138. L.A. Parker, K. Hills, and K. Jensen Behavioral CRs elicited by a lithium- or an amphetamine-paired contextual test chamber Ann. Learn. Behav. 12 1984 307 315
139. L.A. Parker, and S.W. Kemp Tetrahydrocannabinol (THC) interferes with conditioned retching in Suncus murinus: an animal model of anticipatory nausea and vomiting (ANV) Neuroreport 12 2001 749 751
140. L.A. Parker, M. Kwiatkowska, and R. Mechoulam Delta-9- tetrahydrocannabinol and cannabidiol, but not ondansetron, interfere with conditioned retching reactions elicited by a lithium-paired context in Suncus murinus: an animal model of anticipatory nausea and vomiting Physiol. Behav 87 2006 61 71
141. L.A. Parker, C.L. Limebeer, E.M. Rock, D.L. Litt, M. Kwiatkowska, and D. Piomelli The FAAH inhibitor URB-597 interferes with cisplatin- and nicotine-induced vomiting in the Suncus murinus (house musk shrew) Physiol. Behav. 97 2009 121 124
142. L.A. Parker, R. Mechoulam, C. Schlievert, L.A. Abbott, M.L. Fudge, and P. Burton Cannabinoid agonists attenuate and a cannabinoid antagonist potentiates lithium-induced conditioned rejection reactions in a rat model of nausea Psychopharmacology 166 2003 156 162
143. L.A. Parker, S.A. Rana, and C.L. Limebeer Conditioned disgust, but not conditioned taste avoidance: a measure of conditioned nausea in rats Can. J. Exp. Psychol. 62 2008 198 209
144. L.A. Parker, E.M. Rock, and C.L. Limebeer Regulation of nausea and vomiting by cannabinoids Br. J. Pharmacol. 163 2011 1411 1422
145. E.R. Partosoedarso, T.P. Abrahams, R.T. Scullion, J.M. Moerschbaecher, and P.J. Hornby Cannabinoid1 receptor in the dorsal vagal complex modulates lower oesophageal sphincter relaxation in ferrets J. Physiol. 550 2003 149 158
146. C.L. Patil, E.T. Abrams, A.R. Steinmetz, and S.L. Young Appetite sensations and nausea and vomiting in pregnancy: an overview of the explanations Ecol. Food Nutr. 51 2012 394 417
147. M.L. Pelchat, H.J. Grill, P. Rozin, and J. Jacobs Quality of acquired responses to tastes by Rattus norvegicus depends on type of associated discomfort J. Comp. Psychol. 97 1983 140 153
148. W. Penfield, and M.E. Faulk Jr. The insula; further observations on its function Brain 78 1955 445 470
149. Sert N. Percie du, W.S. Ho, J.A. Rudd, and P.L. Andrews Cannabinoid-induced reduction in antral pacemaker frequency: a telemetric study in the ferret Neurogastroenterol. Motil. 22 1257-66 2010 e324
150. R.G. Pertwee Emerging strategies for exploiting cannabinoid receptor agonists as medicines Br. J. Pharmacol. 156 2009 397 411
151. R.G. Pertwee, A.C. Howlett, M.E. Abood, S.P. Alexander, M.V. Di, M.R. Elphick, P.J. Greasley, H.S. Hansen, G. Kunos, K. Mackie, R. Mechoulam, and R.A. Ross International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB(1) and CB(2) Pharmacol. Rev. 62 2010 588 631
152. F.X. Pi-Sunyer, L.J. Aronne, H.M. Heshmati, J. Devin, and J. Rosenstock Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial JAMA 295 2006 761 775
153. D. Piomelli The molecular logic of endocannabinoid signalling Nat. Rev. Neurosci. 4 2003 873 884
154. S. Poli-Bigelli, J. Rodrigues-Pereira, A.D. Carides, G. Julie Ma, K. Eldridge, A. Hipple, J.K. Evans, K.J. Horgan, F. Lawson Aprepitant Protocol 054 Study Group Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America Cancer 97 2003 3090 3098
155. M. Pomeroy, J.J. Fennelly, and M. Towers Prospective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis Cancer Chemother. Pharmacol 17 1986 285 288
156. A.P. Ray, S. Chebolu, and N.A. Darmani Receptor-selective agonists induce emesis and Fos expression in the brain and enteric nervous system of the least shrew (Cryptotis parva) Pharmacol. Biochem. Behav 94 2009 211 218
157. E.M. Rock, D. Bolognini, C.L. Limebeer, M.G. Cascio, S. Anavi-Goffer, P.J. Fletcher, R. Mechoulam, R.G. Pertwee, and L.A. Parker Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus Br. J. Pharmacol. 165 2012 2620 2634
158. E.M. Rock, R.L. Kopstick, C.L. Limebeer, and L.A. Parker Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus Br. J. Pharm. 2013 10.1111/bph.12316
159. E.M. Rock, C.L. Limebeer, R. Mechoulam, D. Piomelli, and L.A. Parker The
160. E.M. Rock, and L.A. Parker Effect of low doses of cannabidiolic acid and ondansetron on LiCl-induced conditioned gaping (a model of nausea-induced behaviour) in rats Br. J. Pharmacol 169 2013 685 692
161. Rock, E.M., Parker, L.A., 2013b. Suppression of lithium chloride-induced conditioned gaping (a model of nausea-induced behaviour) in rats (using the taste reactivity test) with metoclopramide is enhanced by cannabindiolic acid. Pharmacol. Biochem. Behav. 111, 84-89.
162. C. Rojas, and B.S. Slusher Pharmacological mechanisms of 5-HT(3) and tachykinin NK(1) receptor antagonism to prevent chemotherapy-induced nausea and vomiting Eur. J. Pharmacol 684 2012 1 7
163. J.A. Rudd, K. Yamamoto, A. Yamatodani, and N. Takeda Differential action of ondansetron and dexamethasone to modify cisplatin-induced acute and delayed kaolin consumption («pica») in rats Eur. J. Pharmacol. 454 2002 47 52
164. M. Rutkowska, and H. Gliniak The influence of ACEA - a selective cannabinoid CB1 receptor agonist on whole blood and platelet-poor plasma serotonin concentrations Pharmazie 64 2009 598 601
165. rd Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy New Engl. J. Med 293 1975 795 797
166. G.J. Sanger, and P.L. Andrews Treatment of nausea and vomiting: gaps in our knowledge Auton. Neurosci 129 2006 3 16
167. O. Sanu, and R.F. Lamont Hyperemesis gravidarum: pathogenesis and the use of antiemetic agents Exp. Opin. Pharmacother. 12 2011 737 748
168. J.R. Savinainen, S.M. Saario, and J.T. Laitinen The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors Acta Physiol. (Oxf) 204 2012 267 276
169. J.L. Scavone, K. Mackie, and E.J. Van Bockstaele Characterization of cannabinoid-1 receptors in the locus coeruleus: relationship with mu-opioid receptors Brain Res. 1312 2010 18 31
170. F. Schmäl Neuronal mechanisms and the treatment of motion sickness Pharmacology 91 2013 229 241
171. N.L. Schramm-Sapyta, Y.M. Cha, S. Chaudhry, W.A. Wilson, H.S. Swartzwelder, and C.M. Kuhn Differential anxiogenic, aversive, and locomotor effects of THC in adolescent and adult rats Psychopharmacology. (Berl) 191 2007 867 877
172. K.A. Sharkey, L. Cristino, L.D. Oland, M.D. Van Sickle, K. Starowicz, Q.J. Pittman, V. Guglielmotti, J.S. Davison, and V. Di Marzo Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret Eur. J. Neurosci. 25 2007 2773 2782
173. P.W. Sherman, and S.M. Flaxman Nausea and vomiting of pregnancy in an evolutionary perspective Am. J. Obstet. Gynecol. 186 2002 S190 S197
174. I.I. Simoneau, M.S. Hamza, H.P. Mata, E.M. Siegel, T.W. Vanderah, F. Porreca, A. Makriyannis, and T.P. Malan Jr. The cannabinoid agonist WIN55, 212-2 suppresses opioid-induced emesis in ferrets Anesthesiology 94 2001 882 887
175. D.A. Simonetto, A.S. Oxentenko, M.L. Herman, and J.H. Szostek Cannabinoid hyperemesis: a case series of 98 patients Mayo Clin. Proc. 87 2012 114 119
176. K.S. Sink, P.J. McLaughlin, J.A. Wood, C. Brown, P. Fan, V.K. Vemuri, Y. Peng, T. Olszewska, G.A. Thakur, A. Makriyannis, L.A. Parker, and J.D. Salamone The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats Neuropsychopharmacology 33 2008 946 955
177. N. Steele, R.J. Gralla, D.W. Braun Jr., and C.W. Young Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis Cancer Treat. Rep 64 1980 219 224
178. F. Steindel, R. Lerner, M. Haring, S. Ruehle, G. Marsicano, B. Lutz, and K. Monory Neuron-type specific cannabinoid-mediated G protein signalling in mouse hippocampus J. Neurochem. 124 2013 795 807
179. R.M. Stern, K.L. Koch, and P.L. Andrews Nausea: Mechanisms and Management 2011 Oxford University Press Oxford
180. M.A. Sticht, J.Z. Long, E.M. Rock, C.L. Limebeer, R. Mechoulam, B.F. Cravatt, and L.A. Parker The MAGL inhibitor, JZL184, attenuates LiCl-induced vomiting in the Suncus murinus and 2-AG attenuates LiCl-induced nausea-like behaviour in rats Br. J. Pharmacol. 165 2011 2425 2435
181. M.A. Sticht, J.Z. Long, E.M. Rock, C.L. Limebeer, R. Mechoulam, B.F. Cravatt, and L.A. Parker Inhibition of monoacylglycerol lipase attenuates vomiting in Suncus murinus and 2-arachidonoyl glycerol attenuates nausea in rats Br. J. Pharmacol. 165 2012 2425 2435
182. J. Suárez, S.Y. Romero-Zerbo, P. Rivera, F.J. Bermudez-Silva, J. Perez, F.R. de Fonseca, and P. Fernandez-Llebrez Endocannabinoid system in the adult rat circumventricular areas: an immunohistochemical study J. Comp. Neurol. 518 2010 3065 3085
183. D.L. Sweet, N.J. Miller, W. Weddington, E. Senay, and L. Sushelsky delta 9-Tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A pilot study J. Clin. Pharmacol. 21 1981 70S 75S
184. M.R. Tramèr, D. Carroll, F.A. Campbell, D.J. Reynolds, R.A. Moore, and H.J. McQuay Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review BMJ 323 2001 16 21
185. K. Tsou, M.I. Nogueron, S. Muthian, M.C. Sanudo-Pena, C.J. Hillard, D.G. Deutsch, and J.M. Walker Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry Neurosci. Lett. 254 1998 137 140
186. K.J. Tuerke, C.L. Limebeer, P.J. Fletcher, and L.A. Parker Double dissociation between regulation of conditioned disgust and taste avoidance by serotonin availability at the 5-HT3 receptor in the posterior and anterior insular cortex J. Neurosci 32 2012 13709 13717
187. K.J. Tuerke, B.D. Winters, and L.A. Parker Ondansetron interferes with unconditioned lying-on belly and acquisition of conditioned gaping induced by LiCl as models of nausea-induced behaviors in rats Physiol. Behav 105 2012 856 860
188. N. Ueda, K. Tsuboi, and T. Uyama Enzymological studies on the biosynthesis of N-acylethanolamines Biochim. Biophys. Acta 1801 2010 1274 1285
189. N. Ueda, K. Tsuboi, T. Uyama, and T. Ohnishi Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol Biofactors 37 2011 1 7
190. J.T. Ungerleider, T.A. Andrysiak, L.A. Fairbanks, A.S. Tesler, and R.G. Parker Tetrahydrocannabinol vs. prochlorperazine. The effects of two antiemetics on patients undergoing radiotherapy Radiology 150 1984 598 599
191. M.D. Van Sickle, M. Duncan, P.J. Kingsley, A. Mouihate, P. Urbani, K. Mackie, N. Stella, A. Makriyannis, D. Piomelli, J.S. Davison, L.J. Marnett, V. Di Marzo, Q.J. Pittman, K.D. Patel, and K.A. Sharkey Identification and functional characterization of brainstem cannabinoid CB2 receptors Science 310 2005 329 332
192. M.D. Van Sickle, L.D. Oland, W. Ho, C.J. Hillard, K. Mackie, J.S. Davison, and K.A. Sharkey Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret Gastroenterology 121 2001 767 774
193. M.D. Van Sickle, L.D. Oland, K. Mackie, J.S. Davison, and K.A. Sharkey Delta9-tetrahydrocannabinol selectively acts on CB1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets Am. J. Physiol. Gastrointest. Liver Physiol. 285 2003 G566 G576
194. G. Vera, A. Chiarlone, P.A. Cabezos, D. Pascual, M.I. Martin, and R. Abalo WIN 55,212-2 prevents mechanical allodynia but not alterations in feeding behaviour induced by chronic cisplatin in the rat Life Sci. 81 2007 467 479
195. Y. Wang, A.P. Ray, B.A. McClanahan, and N.A. Darmani The antiemetic interaction of delta9-tetrahydrocannabinol when combined with tropisetron or dexamethasone in the least shrew Pharmacol. Biochem. Behav. 91 2009 367 373
196. L.E. Wise, K.A. Long, R.A. Abdullah, J.Z. Long, B.F. Cravatt, and A.H. Lichtman Dual fatty acid amide hydrolase and monoacylglycerol lipase blockade produces THC-like Morris water maze deficits in mice ACS Chem. Neurosci 3 2012 369 378
197. K. Yamamoto, M.P. Ngan, N. Takeda, A. Yamatodani, and J.A. Rudd Differential activity of drugs to induce emesis and pica behavior in Suncus murinus (house musk shrew) and rats Physiol. Behav 83 2004 151 156
198. B.J. Yates, A.D. Miller, and J.B. Lucot Physiological basis and pharmacology of motion sickness: an update Brain Res. Bull. 47 1998 395 406
199. T. Yoshida, M. Fukaya, M. Uchigashima, E. Miura, H. Kamiya, M. Kano, and M. Watanabe Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor J. Neurosci. 26 2006 4740 4751